ICL Group Ltd (ICL):企業の財務・戦略的SWOT分析

◆英語タイトル:ICL Group Ltd (ICL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCH30403FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:67
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:Chemicals
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ICL Group Ltd (ICL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ICL Group Ltd (ICL) is a chemical and specialty mineral company. It manufactures products based on unique minerals for use in agriculture, food and engineered materials. The company’s product portfolio includes bromine, potash, phosphoric acid, phosphate, specialty fertilizers and flame retardants. ICL produces and markets bromine and phosphorus compounds for the automotive, construction, electronics, and oil and gas industries. It also manufactures magnesium and provides water desalination solutions. The company has mining and production plants in Israel, Europe, North and South America, and China. It operates through a broad logistics and distribution network across the world. ICL is headquartered in Tel Aviv, Israel.

ICL Group Ltd Key Recent Developments

Apr 15,2021: ICL Announces First Quarter 2021 Earnings Call
Apr 05,2021: ICL inks contract to supply 600,000 metric tons of potash to India during 2021
Mar 17,2021: ICL Announces Strategic Additions to Executive Leadership and Board of Directors
Feb 11,2021: ICL reports full year and strong fourth quarter results
Dec 21,2020: ICL receives global recognition for its efforts in dealing with climate change

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ICL Group Ltd – Key Facts
ICL Group Ltd – Key Employees
ICL Group Ltd – Key Employee Biographies
ICL Group Ltd – Major Products and Services
ICL Group Ltd – History
ICL Group Ltd – Company Statement
ICL Group Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ICL Group Ltd – Business Description
Business Segment: Industrial Products
Overview
Performance
Key Stats
Business Segment: Innovative Ag Solutions
Overview
Performance
Key Stats
Business Segment: Other Activities
Performance
Business Segment: Phosphate Solutions
Overview
Performance
Key Stats
Business Segment: Potash
Overview
Performance
Key Stats
Geographical Segment: All Other
Performance
Geographical Segment: Brazil
Performance
Geographical Segment: China
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: India
Performance
Geographical Segment: Israel
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Spain
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
R&D Overview
ICL Group Ltd – Corporate Strategy
ICL Group Ltd – SWOT Analysis
SWOT Analysis – Overview
ICL Group Ltd – Strengths
ICL Group Ltd – Weaknesses
ICL Group Ltd – Opportunities
ICL Group Ltd – Threats
ICL Group Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
ICL Group Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
Apr 15, 2021: ICL Announces First Quarter 2021 Earnings Call
Apr 05, 2021: ICL inks contract to supply 600,000 metric tons of potash to India during 2021
Mar 17, 2021: ICL Announces Strategic Additions to Executive Leadership and Board of Directors
Feb 11, 2021: ICL reports full year and strong fourth quarter results
Dec 21, 2020: ICL receives global recognition for its efforts in dealing with climate change
Jul 29, 2020: ICL reports resilient second quarter 2020 results
Jul 13, 2020: ICL announces inclusion in FTSE4Good index series
Jul 09, 2020: ICL expands polysulphate distribution network with long-term distribution agreements
Jul 02, 2020: ICL Announces Release Date and Conference Call Details for Q2 2020 Results
May 12, 2020: ICL reports solid first quarter 2020 results
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ICL Group Ltd, Key Facts
ICL Group Ltd, Key Employees
ICL Group Ltd, Key Employee Biographies
ICL Group Ltd, Major Products and Services
ICL Group Ltd, History
ICL Group Ltd, Subsidiaries
ICL Group Ltd, Key Competitors
ICL Group Ltd, Ratios based on current share price
ICL Group Ltd, Annual Ratios
ICL Group Ltd, Annual Ratios (Cont...1)
ICL Group Ltd, Annual Ratios (Cont...2)
ICL Group Ltd, Interim Ratios
ICL Group Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[ICL Group Ltd (ICL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Merck KGaA:企業のM&A・事業提携・投資動向
    Merck KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merck KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • InTouch Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary InTouch Technologies Inc (InTouch Health) is a healthcare technology company that provides Telehealth Network, comprised of telehealth systems, clinical workflow solutions, software and managed services to healthcare systems and hospitals for the delivery of clinical care. The company’s tele …
  • BioRestorative Therapies Inc (BRTX)-医療機器分野:企業M&A・提携分析
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • Pebblebrook Hotel Trust:企業のM&A・事業提携・投資動向
    Pebblebrook Hotel Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pebblebrook Hotel Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Lombard Odier Private Clients:企業の戦略・SWOT・財務情報
    Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report Summary Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Heroux-Devtek Inc.:企業の戦略・SWOT・財務情報
    Heroux-Devtek Inc. - Strategy, SWOT and Corporate Finance Report Summary Heroux-Devtek Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • 3D Systems Corporation:戦略・SWOT・企業財務分析
    3D Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary 3D Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cynvenio Biosystems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cynvenio Biosystems Inc (Cynvenio) is a cancer diagnostic company that focuses on transforming cancer treatment and management through the molecular analysis of cancer biomarkers in blood. The company offers products such as lab automation systems, isolation products and proprietary informat …
  • Tivo Corporation:戦略・SWOT・企業財務分析
    Tivo Corporation - Strategy, SWOT and Corporate Finance Report Summary Tivo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Atopix Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …
  • Lloyds Banking Group Plc:企業の戦略・SWOT・財務情報
    Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report Summary Lloyds Banking Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Quest Diagnostics Incorporated:戦略・SWOT・企業財務分析
    Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report Summary Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Norfolk Southern Corp (NSC):企業の財務・戦略的SWOT分析
    Norfolk Southern Corp (NSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • J&P – Avax Sa:企業の戦略・SWOT・財務分析
    J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report Summary J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Qiagen NV (QIA):企業の財務・戦略的SWOT分析
    Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Verge Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Verge Genomics Inc (Verge Genomics) is a drug discovery company that focuses on the discovery of treatments for neurodegenerative diseases using human genomic data and machine learning. The company combines large-scale molecular, genomic and genetic data on multiple platforms and technologie …
  • The Nippon Synthetic Chemical Industry Co., Ltd.:企業の戦略的SWOT分析
    The Nippon Synthetic Chemical Industry Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Lotte Chemical Corp (011170):企業の財務・戦略的SWOT分析
    Lotte Chemical Corp (011170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Gradalis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gradalis Inc (Gradalis), formerly Murex Pharmaceuticals, is a biopharmaceutical company which focuses on the development and commercialization of therapies for the treatment of cancer. Its developmental pipeline comprises of candidates for various cancer indications which include ovarian, br …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆